BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9139869)

  • 1. A one-step DGGE scanning method for detection of mutations in the K-, N-, and H-ras oncogenes: mutations at codons 12, 13 and 61 are rare in B-cell non-Hodgkin's lymphoma.
    Nedergaard T; Guldberg P; Ralfkiaer E; Zeuthen J
    Int J Cancer; 1997 May; 71(3):364-9. PubMed ID: 9139869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Denaturing gradient gel electrophoresis (DGGE) assay for K-ras and N-ras genes: detection of K-ras point mutations in human lung tumour DNA.
    Ridanpää M; Husgafvel-Pursiainen K
    Hum Mol Genet; 1993 Jun; 2(6):639-44. PubMed ID: 8353484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of p53, c-kit, K-ras, and beta-catenin gene in non-Hodgkin's lymphoma of adrenal gland.
    Nakatsuka S; Hongyo T; Syaifudin M; Nomura T; Shingu N; Aozasa K
    Jpn J Cancer Res; 2002 Mar; 93(3):267-74. PubMed ID: 11927008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pattern of mutational involvement of RAS genes in human hematologic malignancies determined by DNA amplification and direct sequencing.
    Ahuja HG; Foti A; Bar-Eli M; Cline MJ
    Blood; 1990 Apr; 75(8):1684-90. PubMed ID: 2183888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR.
    Nollau P; Moser C; Weinland G; Wagener C
    Int J Cancer; 1996 May; 66(3):332-6. PubMed ID: 8621253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis.
    Imai M; Hoshi T; Ogawa K
    Cancer; 1994 Jun; 73(11):2727-33. PubMed ID: 8194013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation of transforming N-ras mutations in codons 12, 13 and 61 by denaturing gradient gel electrophoresis: investigation based on a set of phagemid constructs.
    Burvall K; Ridanpää M; Husgafvel-Pursiainen K; Onfelt A
    Mutat Res; 1993 Feb; 285(2):287-94. PubMed ID: 7678902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of RAS oncogene mutations in human lymphoid malignancies.
    Neri A; Knowles DM; Greco A; McCormick F; Dalla-Favera R
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9268-72. PubMed ID: 3057505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T; Reynolds S; Maronpot R; Anderson M
    Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues.
    Keohavong P; Zhu D; Whiteside TL; Swalsky P; Bakker A; Elder EM; Siegfried JM; Srivastava S; Finkelstein SD
    Anal Biochem; 1997 May; 247(2):394-403. PubMed ID: 9177704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of K-ras mutations by denaturing gradient gel electrophoresis (DGGE): a study on pancreatic cancer.
    Pellegata NS; Losekoot M; Fodde R; Pugliese V; Saccomanno S; Renault B; Bernini LF; Ranzani GN
    Anticancer Res; 1992; 12(5):1731-5. PubMed ID: 1444240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analyses of KRAS exon 1 comparing three different techniques: temporal temperature gradient electrophoresis, constant denaturant capillary electrophoresis and allele specific polymerase chain reaction.
    Bjørheim J; Lystad S; Lindblom A; Kressner U; Westring S; Wahlberg S; Lindmark G; Gaudernack G; Ekstrøm P; Røe J; Thilly WG; Børresen-Dale AL
    Mutat Res; 1998 Jul; 403(1-2):103-12. PubMed ID: 9726011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
    Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
    Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of mammary cancer and lymphoma by multiple, low oral doses of 7,12-dimethylbenz[a]anthracene in SENCAR mice.
    Qing WG; Conti CJ; LaBate M; Johnston D; Slaga TJ; MacLeod MC
    Carcinogenesis; 1997 Mar; 18(3):553-9. PubMed ID: 9067556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of ras gene mutations in human lung cancer: comparison of two screening assays based on the polymerase chain reaction.
    Husgafvel-Pursiainen K; Ridanpää M; Hackman P; Anttila S; Karjalainen A; Onfelt A; Børresen AL; Vainio H
    Environ Health Perspect; 1992 Nov; 98():183-5. PubMed ID: 1486847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of t(14;18), P53 and RAS gene mutations and quantification of residual disease in patients with B-cell non-Hodgkin's lymphoma.
    Cikota BM; Tukić LJ; Tarabar OT; Magić ZM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):535-42. PubMed ID: 18365550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A C-terminal FMS mutation in a patient with B-cell malignancy.
    Baker AH; Ball S; McGlynn H; Whittaker JA; Burnett AK; Padua RA
    Leukemia; 1995 Jan; 9(1):155-8. PubMed ID: 7845011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.